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Abstract
Since the first edition of this book in 2013, many new tools and databases have become
publicly available, as well as several have been discontinued. Here, we present an updated
version of web resources on tuberculosis, providing more detailed information on some
key concepts. However, the purpose of this chapter is by no means to offer an exhaustive
list of all the resources available on the Internet about TB, the topic of this book. This
would be a massive and perhaps futile work since the evolution of the Internet occurs at a
very fast pace. Rather, this chapter concentrates on a selection of the most important,
relevant and stable websites with relevance to several aspects of TB, such as research,
treatment, main institutions, funding, and specialized platforms. We think this should
complement all the other information already presented in this book, offering the reader
a more integrated view of the disease, as well as access to new platforms and systems
specialized in the analysis of data generated by a series of new technologies such as DNA
sequencing.
Keywords: tuberculosis, omics, bioinformatics
1. Introduction
The Internet has quickly become the universal exponent of the digital world as we know it.
Today, billions of people around the world use the Internet as their primary source of informa-
tion and benefit from electronic mail systems, information distribution, file sharing, multime-
dia streaming services, and online social networking, to cite just a few examples. With the
popularization of smartphones, access to the Internet has become even more frequent, and
many people remain connected all the time. This medium is an unprecedented form of
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communication in the history of humanity, capable of bringing information from virtually
anywhere almost instantaneously.
Scientists have been pioneers in benefiting from global interaction and globalized information.
Nowadays, we deal with algorithms, data mining, terabytes and petabytes of data, teraFLOPS
and petaFLOPS to measure computer performance, distributed computing, cloud computing,
and terms and aspects of what we call big data, referring to data sets with huge sizes,
exceeding the capability of commonly used software tools to manage and process these data
within a feasible time frame. This kind of data stems from a variety of new (as well as old)
high-throughput technologies, employed by researchers in different fields, such as astronomy
and (recently) biology, as well as from information technology companies, such as Amazon,
Facebook, and Google, among many other examples. For instance, the Large Hadron Collider,
a particle accelerator at CERN, Switzerland, generates data on the order of terabytes per
second.
However, the global connection is not restricted to the virtual world: with the ease of intercon-
tinental travels, infectious agents can traverse the whole world in one single day. Tuberculosis
(TB) is a disease considered to be at high risk for people who maintain prolonged and repeated
contact with the host. Therefore, the risk of infection when traveling is reduced, but some
conditions might present as a risk factor. Immunocompromised travelers (whether by the
disease itself or by medication), smokers, children under 5 years old, and healthcare workers
are particularly vulnerable to TB. Before traveling, the individual should consult a specialist to
assess the risks of contracting TB in the area of stay, checking the incidence of TB and,
especially, of resistant strains. Prophylactic measures should be taken when necessary, and
medical follow-up should be provided when returning from the trip. These procedures are
critical to containing the global circulation of TB strains [1].
TB is a pandemic disease, with an estimated one-third of the world’s population contaminated
by the bacillus Mycobacterium tuberculosis (Mtb). Although treatable, patients without proper
follow-up usually abandon the therapy as soon as they feel better. This and the indiscriminate
use of antibiotics are causing the emergence of new drug-resistant strains, with patterns of
epidemic or outbreak resembling the dissemination of a new piece of information throughout
the Internet.
On the other hand, there has also been a revolution in other areas. High-performance technol-
ogies, such as genomics, transcriptomics, proteomics, and metabolomics, for instance, offer a
new and more integrated view of the genetics and metabolism of targeted organisms. Cur-
rently, thousands of mycobacterial genomes are already sequenced or are in progress. Hence,
for example, comparing genomes of virulent and non-virulent strains of Mtb, scientists can
pinpoint genes and/or polymorphisms possibly involved in pathogenesis; similarly, analyzing
transcriptome data, researchers might gain an idea of the effects caused by a given drug in the
bacillus’ metabolism.
Since the Internet content is continually updated and changed, providing an exhaustive list of
all the resources available online concerning TB would be a cumbersome and perhaps futile
work. Hence, in this chapter, we present a selection of the most relevant and stable websites
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exploring several aspects of TB, such as treatment, research, and funding, or providing access
to analytical tools, databases, or specialized platforms for mycobacterial research. We hope this
chapter can offer the reader an overview of online, publicly available, computational resources
that could help us to fight TB.
2. Bioinformatics and omics
2.1. Bioinformatics
Bioinformatics is an interdisciplinary field that involves distinct areas, such as biology, computer
science, mathematics, and statistics, comprising an extensive list of activities, such as research,
development, or application of computational techniques or tools to acquire, store, organize,
analyze, visualize, and integrate biological, medical, behavioral, or health data and information.
Bioinformatics addresses scientific questions imposed by biological phenomena applying several
analytical approaches such as image processing, computational simulations, network analysis,
and data mining, among others, to perform comparative genomics studies, gene expression
analysis, structural protein analysis, phylogenetics, and metabolic networks, just to cite a few
examples [2].
However, bioinformatics preceded the term, as its origins can be traced back to the early 1960s
when computers became essential tools in the field of molecular biology, as well as in all other
research areas [3]. At that time, Margaret Oakley Dayhoff, a biochemist with a PhD degree in
quantum chemistry, pioneered the development of computer methods for comparing protein
sequences and for inferring evolutionary histories based on protein sequence alignments.
Among many other significant scientific contributions made during her career, she cataloged
all known protein sequences and made them available to the scientific community, publishing
in 1965 the Atlas of Protein Sequence and Structure, containing sequence information on 65
proteins, considered the first molecular biology database [4].
Indeed, toward the end of the 1960s, several algorithms and computer programs were already
available for analyzing structure, function, and evolution of nucleotide and protein sequences,
as well as rudimentary protein databases [3, 5]. In the following decades, new computational
methods and approaches were introduced such as algorithms for sequence alignments, public
domain databases, efficient data search and retrieval systems, sophisticated methods for pro-
tein structure prediction, tools to automatically annotate genes and genomes, and systems for
functional genome analysis, among others [6].
2.2. Omics
The cost of DNA and RNA sequencing has been gradually decreasing over the years, and the
improvement achieved with new sequencing technologies allows sequencing the whole
genome or transcriptome of an organism in few hours, creating new avenues for biological
research. However, genome sequencing involves the generation of a massive amount of data,
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in the order of hundreds or even thousands of gigabytes. In the same way, but with higher cost
and some technological limitations, mass spectrometry and magnetic resonance imaging are
also capable of identifying thousands of proteins and metabolites of an organism, respectively.
In this context, new “omics” (an informal term that collectively refers to research fields of
biology ending in -omics, such as genomics, proteomics, or metabolomics) approaches have
arisen, involving not only the production of sequence data but also the analysis, treatment, and
interpretation of biological data on a large scale [7]. The following sections briefly present
some of the main “omics” approaches, exemplifying their application in TB research.
2.2.1. Genomics
Genomics is a field of biology that seeks to understand the structure, functions, and evolution of
genes and genomes analyzing large-scale genomic data obtained with high-throughput sequenc-
ing technologies. For instance, whole genome sequencing (WGS) and comparative analyses of
genomic segments (chromosomes or syntenic regions) or the entire genome content (protein-
coding genes, RNA-coding genes, pseudogenes, non-translated regions, etc.) allow the investi-
gation of complex biological phenomena, giving insights into genome evolution and adaptation
over time or even helping to improve clinical diagnoses. In the last two decades, WGS has
become a routine among researchers, and currently there are thousands of completely sequenced
genomes available in public databases. In fact, the availability and accessibility of genomic
sequences are increasing rapidly, with the results generated by teams of researchers in collabo-
rative networks or even in independent laboratories, supporting many essential analyses in the
field, such as comparison of biological sequences and searching for similarities between them,
enabling the inference of functional and evolutionary relationships between genes, gene families,
and genomes [8, 9].
For instance, comparative genomics, together with the combination of archeological data and
DNA sequencing, has already established a plausible evolutionary scenario for the origin of
the principal etiological agent of TB, the pathogen Mtb. Although it is a millennial disease,
drugs for the treatment of TB have appeared less than 100 years ago. Since then, multidrug-
resistant (MDR) strains have emerged, as well as extensively drug-resistant (XDR) strains, and
more recently, several countries have reported cases of total drug-resistant (TDR) strains,
frustrating the efforts to fight TB. A typical feature of bacterial agents that develop drug
resistance is the occurrence of lateral gene transfer (LTG), but comparative genomic studies
did not find evidence of LTG in Mycobacterium tuberculosis complex (MTBC) organisms. Thus,
there is a pathogen adapted for living in human host cells, able to remain for a long time as a
latent disease, surviving in the host and adapting to yield a persistent infection, often immune
to treatments. The primary challenge is then to develop an effective vaccine against most Mtb
strains, which would be possible by targeting conserved elements [10].
2.2.2. Transcriptomics
Transcriptomics is the analysis of gene expression through the sequencing of RNA in large
scale (RNA-Seq). Transcriptome, the whole set of RNA transcripts of a given organism, organ,
tissue, or cell lineage, contains different types of RNAs. Thus, transcriptomics provides
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essential information of the biological sample under analysis, allowing both quantitative and
qualitative approaches to gene expression, providing a profile of all coding and noncoding
transcripts, in specific conditions. RNA-Seq technologies have been improved gradually,
including novel techniques such as single-cell RNA-Seq, in which individual cells of interest
obtained from culture, tissue, or dissociated cell suspensions are isolated, converting RNA into
cDNA and sequencing of cDNA libraries. However, transcriptomics still faces too many
challenges. RNA-Seq produces very short reads and presents a high error rate, yielding a
tremendous amount of data from massively parallel sequencing, requiring significant compu-
tational resources, as well as specific algorithms and software, to analyze it [11–13].
Mtb has an extensively resistant cell wall, can adopt an opportunistic switching over to latency,
and has many strategies that fool the host’s immune system, compromising the effectiveness of
therapeutic approaches available. The analysis of Mtb transcriptome signatures during infec-
tion, for instance, provided by the genome-wide expression profile, showed the expression of
numerous genes used to evade the host immune responses, suitable to the intracellular life-
style, and to respond to various antibiotic drugs [14].
2.2.3. Proteomics
Proteomics establishes a global analysis of a cell’s proteins. Gathering information about the
proteome and comparing it with genome and transcriptome data is the way to understand the
functioning of the cell. The physicochemical properties of highly diversified amino acids,
protein modifications, and degradations and the interconnectivity of proteins in complexes
are examples of difficulties encountered in collecting data compared to the other “omics”
sciences. Nowadays, mass spectrometry is known as the state-of-the-art proteomics and has
been improved with the development of instruments, sample preparation, and new analytical
software. Mass spectrometry is capable of characterizing almost a complete proteome, reveal-
ing the profiling of the expressed proteins at the cellular and subcellular levels, providing
knowledge of the functional status of a cell in response to environmental stimuli [15, 16].
Among all sequenced Mtb strains so far, with different genotypes and phenotypes, only a few
have a complete identification of protein-coding regions, lacking the knowledge of protein
functions that play roles in the physiology of mycobacteria. This information would be essen-
tial to allow, for example, understanding the causes that lead to mechanisms of mycobacterial
pathogenicity and drug resistance. Even then, proteomics has already enabled us to know
some aspects of virulence and its mechanisms of action in Mtb strains. The next step for
proteomics contribution in mycobacteria research, the analysis of the immune response of the
host, is one of the ways to establish new treatment programs, especially in the current scenario
of drug resistance [17].
2.2.4. Metabolomics
Metabolomics encompasses the study of metabolism within a living cell, that is, it deals with the
identification and analysis of biochemical reactions products and their processes within the cell.
The metabolome is the set of these products (metabolites), and the metabolism analysis can
reveal the cell’s organic response. Metabolic analysis is a valuable resource for identification of
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specific metabolite biomarkers, which would help, for example, evaluating response to drugs or
stress agents. Magnetic resonance spectrometry (NMR) and mass spectrometry (MS) are the
appropriate technologies for accurate measurements of metabolites, providing a good pheno-
type representation of any cell [18, 19].
Being complementary to other “omics,” the metabolomics fills some gaps to a better under-
standing of diseases caused by mycobacteria. It is known that mycobacterial exosomes can be
used as biomarkers, since they come from infected cells, containing mycobacterial proteins,
lipoarabinomannan, and metabolites. They have been used for TB diagnosis and in the
research of new vaccines. It is important to emphasize that the signatures of TB biomarkers
must be validated in geographical and ethnical context, given the worldwide and diversified
nature of the strains, besides concomitant infections such as malaria and HIV, as they affect
metabolic biosignatures [19, 20].
2.3. One example of integration of omics
An effective vaccine for all strains of TB and the development of therapeutic approaches
appropriate to the variations and stages of the disease are the main goals of current research
in TB. The achievement of the genomic expression catalog of a global collection of BCG vaccine
strains, comparing genomes and transcriptomes of 14 of the most widely used BCG strains, is
one example of interaction between “omics” sciences in TB research, contributing to display
evidences for highly diverged metabolic and cell-wall adaptations. Moreover, quantitative
proteomics has identified the major differences in protein expression, when changes observed
in the proteome confirmed the changes observed in the transcriptome, showing how the
adaptation to the environment causes phenotypic differences between BCGs [21].
3. Tuberculosis facts, information, and treatment research
This section presents websites covering diverse information about TB, including history, path-
ogenesis, transmission, epidemiology, diagnosis, treatment, and infection control, listed in
alphabetical order (Table 1). They also provide information about courses, tokens, and links
Agency URL
Americas American Lung Association (ALA) Lung Disease
Programs
http://www.lung.org/
American Public Health Association https://www.apha.org/
Bill & Melinda Gates Foundation https://www.gatesfoundation.org/
Centers for Disease Control and Prevention,
Division of Tuberculosis Elimination (CDC-DTBE)
https://www.cdc.gov/tb/
Food and Drug Administration (FDA) https://www.fda.gov/default.htm
Global Tuberculosis Institute http://globaltb.njms.rutgers.edu/
Institute for Tuberculosis Research http://www.tuberculosisdrugresearch.org/
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to other websites and general guidelines. We do not prioritize any of them since every effort
made to combat this disease has become important because of its comprehensiveness.
4. Tuberculosis databases and computational tools
Bioinformatics had its origins in the 1960s when computers became essential tools in research.
Since then, numerous computational resources have been created, providing the scientific
community different analytical tools to interpret a range of biological data. Collectively, these
online resources are publicly available and are dedicated to acquire, store, organize, analyze,
visualize, and/or integrate the ever-increasing amount of biological data originated from
scientific experiments, scientific literature, high-throughput technologies, and computational
analyses.
Agency URL
National Institute of Allergy and Infectious
Diseases (NIAID)
https://www.niaid.nih.gov/
National Library of Medicine, PubMed https://www.ncbi.nlm.nih.gov/pubmed/
Pan American Health Organization (PAHO) http://www.paho.org/
Africa AllAfrica.com: TB News from Africa http://allafrica.com/tuberculosis/
Desmond Tutu TB Centre http://www0.sun.ac.za/dttc/
South African Tuberculosis Vaccine Initiative http://www.satvi.uct.ac.za/
Tb Alliance https://www.tballiance.org/
Asia and
Oceania
JATA, Research Institute of Tuberculosis http://www.jata.or.jp/eindex/home.html
National Institute for Research in Tuberculosis http://www.trc-chennai.org/
Pakistan Anti-TB Association http://www.patba.org/
TBC India http://www.tbcindia.nic.in/
Europe European Tuberculosis Surveillance Network https://ecdc.europa.eu/en/about-us/partnerships-and-
networks/disease-and-laboratory-networks/european-
tuberculosis/
International Union Against Tuberculosis and
Lung Disease (UNION)
https://www.theunion.org/
Max Planck Institute for Infection Biology http://www.mpiib-berlin.mpg.de/
National Health Service in England http://www.nhs.uk/conditions/Tuberculosis/Pages/
Introduction.aspx
Pasteur Institute https://www.pasteur.fr/
StopTB Partnership http://www.stoptb.org/
TBnet http://www.tb-net.org/
Global World Health Organization (WHO) http://who.int/tb/en/
Table 1. Websites covering TB facts, information, and treatment research.
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In this section, we provide a selection of online publicly available resources (entirely or
partially) dedicated to mycobacteria causing tuberculosis, categorized according to its purpose
and functionality (Table 2). Each category is quickly reviewed, presenting the reference to the
original paper describing each computational tool, as well as its electronic address.
Category Resource URL Ref.
Generic and
multifunctional
resources
Resources for functional and evolutionary
genomic study of the genusMycobacterium,
comprising extensive literature review and
data annotation on mycobacterial genome
polymorphism, virulence factors, in silico
generated and manually reviewed
information on the complete genome
sequence of these organisms, and essential
genes
MyBASE http://mybase.psych.ac.cn/ [22]
The MycoBrowser
portal
http://mycobrowser.epfl.ch/ [23]
Genomic
mapping and
functional
annotation
Systems supporting functional annotation,
including protein analysis, subcellular
localization prediction, and mycobacterial
membrane protein identification and
characterization
MycoMemSVM http://lin.uestc.edu.cn/
server/MycoMemSVM
[24]
MycoSub http://lin.uestc.edu.cn/
server/Mycosub/
[25]
Genolist
(TubercuList,
BoviList, BCGList)
http://genolist.pasteur.fr/ [26,
27]
Comparative
genomics
Collection of databases dedicated to
mycobacterial comparative genomics,
providing precomputed data of
comparative genome analyses among
selected mycobacterial genera, as well as
inferred orthologous groups, functional
annotations, and protein features
GenoMycDB http://genomycdb.fiocruz.br/ [28]
MycoDB http://xbase.warwick.ac.uk/
mycodb/
[29]
Mycobacterium
tuberculosis
Comparative
Database
https://olive.broadinstitute.
org/projects/Mycobacterium
tuberculosis Comparative
[30]
Genetic
diversity and
epidemiology
Focused on genetic diversity and
epidemiology of MTBC, providing
information of epidemiological data, strain
lineage, genotyping, and phylogeny. They
offer analyses of mycobacterial
interspersed repetitive units (MIRU),
single nucleotide polymorphism (SNP),
long sequence polymorphism (LSP),
spoligotyping patterns, IS6110-based
restriction fragment length polymorphism
(RFLP), and regions of difference (RD)
profiles
CASTB http://castb.ri.ncgm.go.jp/
CASTB/
[31]
MIRU-VNTRplus http://www.miru-vntrplus.
org/
[32,
33]
PhyTB http://pathogenseq.lshtm.ac.
uk/phytblive/index.php
[34]
PolyTB http://pathogenseq.lshtm.ac.
uk/polytblive/browser.php
http://pathogenseq.lshtm.ac.
uk/polytblive/map.php
http://pathogenseq.lshtm.ac.
uk/polytblive/phy.php
[35]
SITVITWEB http://www.pasteur-
guadeloupe.fr:8081/
SITVIT_ONLINE/
[36]
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Category Resource URL Ref.
SpolSimilaritySearch http://www.pasteur-
guadeloupe.fr:8081/
SpolSimilaritySearch/
[37]
spolTools http://spoltools.emi.unsw.
edu.au/
[38]
TB-Insight http://tbinsight.cs.rpi.edu/ [39]
Gene
expression and
regulation
Provide data on mycobacterial
transcription factors, predicted operons,
predicted transcriptional units, gene
expression, and regulatory networks
CMRegNet http://lgcm.icb.ufmg.br/
cmregnet/
[40]
GeNET http://bengi.cs.mun.ca/genet/ [41]
MTBRegList http://www.usherbrooke.ca/
vers/MtbRegList/
[42]
MycoperonDB http://cdfd.org.in/
mycoperondb/home.html
[43]
Structural
biology
These tools use three-dimensional models
of mycobacterial proteins to provide
information of domain assignments,
functional annotation protein-protein or
protein-small molecule interactions, and
structural analyses of mutations
potentially associated with drug resistance
CHOPIN http://mordred.bioc.cam.ac.
uk/chopin/
[44]
SInCRe http://proline.biochem.iisc.
ernet.in/sincre/
[45]
Drug targets
and resistance
Tools for diagnosis of drug resistance in
tuberculosis, new vaccines, and drug
targets
AuTuMN TB-
modeling
http://www.tb-modelling.
com/mdr_tb_at_retreatment/
[46]
MtbVeb http://crdd.osdd.net/
raghava/mtbveb/
[47]
MUBII-TB-DB http://umr5558-
bibiserv.univ-lyon1.fr/
mubii/mubii-select.cgi/
[48]
MycobacRV http://mycobacteriarv.igib.
res.in/
[49]
PhyResSE http://phyresse.org/ [50]
TB Drug Resistance
Mutation Database
https://tbdreamdb.ki.se/Info/ [51]
TB-Profiler http://tbdr.lshtm.ac.uk/ [52]
TDR Targets
database
http://tdrtargets.org/ [53]
TIBLE http://mordred.bioc.cam.ac.
uk/tible/
[54]
TuberQ http://tuberq.proteinq.com.
ar/
[55]
Table 2. Online publicly available resources dedicated to mycobacteria causing tuberculosis.
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